Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call By: Simulations Plus, Inc. via Business Wire October 11, 2021 at 16:15 PM EDT Conference Call to be on Monday, October 25, 2021, at 5:00 PM ET Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its fourth quarter and full year financial results for fiscal year 2021, ended August 31, 2021, after the close of the financial markets on Monday, October 25, 2021. The Company will host a conference call on October 25, 2021, at 5:00 p.m. Eastern Time. All interested parties are invited to join the call by registering here or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be available on the Investors page of the Simulations Plus website under Conference Calls & Presentations. A replay of the webcast will be available on the website approximately one hour following the call. About Simulations Plus, Inc. Serving clients worldwide for 25 years, Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | Read our Environmental, Social, and Governance (ESG) Report. View source version on businesswire.com: https://www.businesswire.com/news/home/20211011005186/en/Contacts Simulations Plus Investor Relations Ms. Renee Bouche 661-723-7723 renee@simulations-plus.com Hayden IR Mr. Brian Siegel 346-396-8696 brian@haydenir.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2021 Earnings Release and Conference Call By: Simulations Plus, Inc. via Business Wire October 11, 2021 at 16:15 PM EDT Conference Call to be on Monday, October 25, 2021, at 5:00 PM ET Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its fourth quarter and full year financial results for fiscal year 2021, ended August 31, 2021, after the close of the financial markets on Monday, October 25, 2021. The Company will host a conference call on October 25, 2021, at 5:00 p.m. Eastern Time. All interested parties are invited to join the call by registering here or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be available on the Investors page of the Simulations Plus website under Conference Calls & Presentations. A replay of the webcast will be available on the website approximately one hour following the call. About Simulations Plus, Inc. Serving clients worldwide for 25 years, Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | Read our Environmental, Social, and Governance (ESG) Report. View source version on businesswire.com: https://www.businesswire.com/news/home/20211011005186/en/Contacts Simulations Plus Investor Relations Ms. Renee Bouche 661-723-7723 renee@simulations-plus.com Hayden IR Mr. Brian Siegel 346-396-8696 brian@haydenir.com
Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its fourth quarter and full year financial results for fiscal year 2021, ended August 31, 2021, after the close of the financial markets on Monday, October 25, 2021. The Company will host a conference call on October 25, 2021, at 5:00 p.m. Eastern Time. All interested parties are invited to join the call by registering here or by calling 1-201-389-0879. Please join five to 10 minutes before the scheduled start time. The call will be simulcast live on the Internet, and the webcast will be available on the Investors page of the Simulations Plus website under Conference Calls & Presentations. A replay of the webcast will be available on the website approximately one hour following the call. About Simulations Plus, Inc. Serving clients worldwide for 25 years, Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | Read our Environmental, Social, and Governance (ESG) Report. View source version on businesswire.com: https://www.businesswire.com/news/home/20211011005186/en/
Simulations Plus Investor Relations Ms. Renee Bouche 661-723-7723 renee@simulations-plus.com Hayden IR Mr. Brian Siegel 346-396-8696 brian@haydenir.com